Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease by Institute of Medicine, Food and Nutrition Board, Board on Health Sciences Policy

Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease

Institute of Medicine, Food and Nutrition Board, Board on Health Sciences Policy

334 pages missing pub info (editions)

nonfiction health technology
Powered by AI (Beta)
Loading...

Description

Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scien...

Read more

Community Reviews

Loading...

Content Warnings

Loading...